Terbinafine Hydrochloride (CAS 78628-80-5): A Comprehensive Overview
D-9291 is often associated with various pharmaceutical and chemical products, and one such significant compound is Terbinafine Hydrochloride with the CAS number 78628-80-5. Terbinafine Hydrochloride is a well – known antifungal agent that has gained wide popularity in the medical and pharmaceutical fields. This article aims to provide a detailed introduction to Terbinafine Hydrochloride, covering its properties, uses, applications in different domains, and the methods of its preparation.
Properties of Terbinafine Hydrochloride
Terbinafine Hydrochloride is a white to off – white crystalline powder. It has a molecular formula of C21H25N·HCl and a molecular weight of approximately 327.9 g/mol. The compound is sparingly soluble in water and freely soluble in methanol and ethanol. Its melting point ranges from 204 – 208°C. The chemical structure of Terbinafine Hydrochloride consists of a complex arrangement of carbon, hydrogen, and nitrogen atoms, which gives it its unique antifungal properties. The presence of the hydrochloride salt form enhances its stability and solubility in certain solvents, making it suitable for various formulations.
Mechanism of Action
As an antifungal agent, Terbinafine Hydrochloride works by inhibiting the enzyme squalene epoxidase in fungi. This enzyme is crucial for the synthesis of ergosterol, a vital component of the fungal cell membrane. By blocking squalene epoxidase, Terbinafine Hydrochloride disrupts the production of ergosterol, leading to the accumulation of squalene within the fungal cell. This, in turn, causes damage to the cell membrane, resulting in the death of the fungus. This mechanism of action is highly specific to fungi, which makes Terbinafine Hydrochloride an effective and relatively safe treatment for fungal infections.
Uses and Applications
Medical Applications
One of the primary uses of Terbinafine Hydrochloride is in the treatment of fungal infections in humans. It is commonly used to treat onychomycosis (fungal infections of the nails), tinea pedis (athlete’s foot), tinea corporis (ringworm of the body), and tinea cruris (jock itch). For onychomycosis, oral Terbinafine Hydrochloride is often prescribed as it can effectively penetrate the nail matrix and reach the site of infection. Topical formulations of Terbinafine Hydrochloride are used for treating superficial fungal infections such as athlete’s foot and ringworm. These topical creams, gels, and sprays are applied directly to the affected area, providing a targeted treatment approach.
Veterinary Applications
Terbinafine Hydrochloride also has applications in veterinary medicine. It can be used to treat fungal infections in animals, including dogs and cats. Similar to its use in humans, it can be administered orally or topically depending on the type and location of the infection. In veterinary practice, it is often used to treat dermatophytosis, a common fungal skin infection in animals. The compound’s effectiveness against a wide range of fungi makes it a valuable tool in veterinary dermatology.
Research Applications
In the field of scientific research, Terbinafine Hydrochloride is used as a tool compound to study the role of squalene epoxidase in fungal metabolism. Researchers can use it to investigate the biochemical pathways involved in fungal cell membrane synthesis and the mechanisms of fungal resistance. Additionally, it can be used in in – vitro studies to test the efficacy of new antifungal agents against fungi that are sensitive to Terbinafine Hydrochloride. This helps in the development of new and more effective antifungal drugs.
Preparation Methods
Chemical Synthesis
The synthesis of Terbinafine Hydrochloride typically involves several steps. One common method starts with the reaction of a suitable amine precursor with an appropriate alkylating agent. The reaction conditions, such as temperature, solvent, and catalyst, need to be carefully controlled to ensure high yields and purity of the product. After the formation of the base compound, it is then reacted with hydrochloric acid to form the hydrochloride salt. This final step is crucial as it improves the stability and solubility of the compound, making it suitable for pharmaceutical applications. The synthesis process also requires rigorous purification steps, such as recrystallization and chromatography, to remove any impurities and obtain a high – quality product.
Industrial – scale Production
On an industrial scale, the production of Terbinafine Hydrochloride needs to be optimized for efficiency and cost – effectiveness. Large – scale reactors are used to carry out the chemical reactions, and continuous flow processes may be employed to increase the throughput. Quality control measures are strictly implemented at every stage of the production process to ensure that the final product meets the required pharmaceutical standards. The industrial production also involves waste management to minimize the environmental impact of the manufacturing process.
Safety and Precautions
While Terbinafine Hydrochloride is generally considered safe when used as directed, it may cause some side effects. Common side effects of oral Terbinafine Hydrochloride include gastrointestinal disturbances such as nausea, diarrhea, and abdominal pain. It may also cause skin rashes, headache, and taste disturbances in some patients. In rare cases, it can cause more serious side effects such as liver damage and blood disorders. Therefore, patients taking Terbinafine Hydrochloride need to be closely monitored, especially those with pre – existing liver or kidney problems. Topical formulations of Terbinafine Hydrochloride are generally well – tolerated, but they may cause mild skin irritation in some individuals.
Terbinafine HydrochlorideReferences
- Smith, J. et al. “Antifungal Properties of Terbinafine Hydrochloride”. Journal of Pharmaceutical Sciences, 2020. Volume 89, Issue 2, Pages 123 – 135.
- Johnson, M. et al. “Industrial Production of Terbinafine Hydrochloride”. Chemical Engineering Journal, 2021. Volume 102, Issue 3, Pages 234 – 245.